Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 912 | 1200 | 794 | - | - | - |
Fund Return | -8.78% | 20.04% | -20.62% | - | - | - |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
HSBC Jintrust Carbon Awareness Eq | 3.91B | -12.17 | -12.24 | 7.35 | ||
HSBC Jintrust Dynamic Strategy H | 2.87B | -12.66 | -8.83 | - | ||
HSBC Jintrust Dynamic Strategy A | 2.87B | -12.66 | -8.75 | 14.91 | ||
HSBC Jintrust Large Cap Equity Secu | 2.4B | 4.88 | -9.87 | 14.58 | ||
Jintrust Large Cap Equity Sec Inv H | 2.4B | 4.88 | -9.89 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Zhongou Medical and Health Hybrid A | 36.88B | -12.22 | -23.72 | - | ||
Zhongou Medical and Health Hybrid C | 36.88B | -12.46 | -24.32 | - | ||
E Healthcare Secotor | 5.91B | -2.89 | -7.64 | 10.63 | ||
Rongtong Healthy Indus Flexible All | 4.46B | -10.49 | -3.93 | - | ||
Fullgoal Precision Medical Mix Fund | 3.05B | 3.02 | -13.71 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Suzhou Zelgen Biopharma | CNE100003RP1 | 9.81 | 53.27 | -2.42% | |
Mabwell Shanghai Bioscience | CNE100005RD2 | 9.57 | 33.16 | -1.37% | |
Jiangsu Hengrui | CNE0000014W7 | 9.28 | 44.69 | +0.04% | |
Keymed Biosciences Inc | - | 8.59 | - | - | |
Chongqing Genrix Biopharmaceutical Co Ltd Ordinary Shares - Class A | - | 6.81 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Neutral | Sell |
Technical Indicators | Sell | Strong Buy | Strong Sell |
Summary | Sell | Buy | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review